Most patients suffering from Lyme disease are effectively treated with antibiotics. In some patients, however, problems persist for a long time despite appropriate therapy. The term post-treatment Lyme disease syndrome (PTLDS) is currently used for this condition in scientific literature. The pathogenesis is still not precisely known, but the involvement of immunopathological mechanisms is assumed. In our study, we analyzed the presence of autoantibodies including myositis-specific (MSA) and myositis-associated autoantibodies (MAA) in patients with laboratory proven history of Lyme disease and with clinical symptoms of PTLDS. A total of 59 patients meeting the criteria for PTLDS were enrolled in this study. The control group consisted of 40 patients undergoing differential diagnosis of neurological disorders without clinical and/or laboratory-proven history of Lyme disease. The presence of autoantibodies was determined by immunoblot methods and positive samples were further tested for serum creatine kinase (CK) and myoglobin levels. The presence of myositis autoantibodies was detected in 18 subjects with suspected PTLDS (30.5%), but only in 5% of control subjects exhibiting no evidence of Lyme disease history. The difference was statistically significant (p = 0.002). The subsequent biochemical analysis of muscle-damage markers in positive subjects found a mild elevation in six MSA/MAA-positive PTLDS patients. The study detected raised MSA/MAA autoantibodies formation in the group of PTLDS patients raising the question about their involvement in the pathogenesis of this syndrome.

3rd Department of Internal Medicine Nephrology Rheumatology and Endocrinology University Hospital Olomouc Zdravotniku 248 7 779 00 Olomouc Czech Republic

Department of Allergology and Clinical Immunology University Hospital Olomouc Zdravotniku 248 7 779 00 Olomouc Czech Republic

Department of Immunology Faculty of Medicine and Dentistry Palacky University Olomouc Hnevotinska 3 779 00 Olomouc Czech Republic

Department of Immunology University Hospital Olomouc Zdravotniku 248 7 779 00 Olomouc Czech Republic

Department of Medical Biophysics Faculty of Medicine and Dentistry Palacky University Olomouc Hnevotinska 3 779 00 Olomouc Czech Republic

Department of Neurology University Hospital Olomouc Zdravotniku 248 7 779 00 Olomouc Czech Republic

Zobrazit více v PubMed

Steere A.C., Strle F., Wormser G.P., Hu L.T., Branda J.A., Hovius J.W.R., Li X., Mead P.S. Lyme borreliosis. Nat. Rev. Dis. Prim. 2016;2:16090. doi: 10.1038/nrdp.2016.90. PubMed DOI PMC

Krupka M., Raska M., Belakova J., Horynova M., Novotny R., Weigl E. Biological aspects of Lyme disease spirochetes: Unique bacteria of the Borrelia burgdorferi species group. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub. 2007;151:175–186. doi: 10.5507/bp.2007.032. PubMed DOI

Mead P.S. Epidemiology of Lyme Disease. Infect. Dis. Clin. North Am. 2015;29:187–210. doi: 10.1016/j.idc.2015.02.010. PubMed DOI

Rudenko N., Golovchenko M., Grubhoffer L., Oliver J.H. Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick-Borne Dis. 2011;2:123–128. doi: 10.1016/j.ttbdis.2011.04.002. PubMed DOI PMC

Gern L. Borrelia burgdorferi sensu lato, the agent of lyme borreliosis: Life in the wilds. Parasite. 2008;15:244–247. doi: 10.1051/parasite/2008153244. PubMed DOI

Krupka M., Zachova K., Weigl E., Raska M. Prevention of lyme disease: Promising research or sisyphean task? Arch. Immunol. Ther. Exp. 2011;59:261–275. doi: 10.1007/s00005-011-0128-z. PubMed DOI

Cerar D., Cerar T., Ruzić-Sabljić E., Wormser G.P., Strle F. Subjective symptoms after treatment of early Lyme disease. Am. J. Med. 2010;123:79–86. doi: 10.1016/j.amjmed.2009.05.011. PubMed DOI

Wormser G.P., Dattwyler R.J., Shapiro E.D., Halperin J.J., Steere A.C., Klempner M.S., Krause P.J., Bakken J.S., Strle F., Stanek G., et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2006;43:1089–1134. doi: 10.1086/508667. PubMed DOI

Nemeth J., Bernasconi E., Heininger U., Abbas M., Nadal D., Strahm C., Erb S., Zimmerli S., Furrer H., Delaloye J., et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med. Wkly. 2016;146:w14353. doi: 10.4414/smw.2016.14353. PubMed DOI

Aucott J.N. Posttreatment Lyme Disease Syndrome. Infect. Dis. Clin. N. Am. 2015;29:309–323. doi: 10.1016/j.idc.2015.02.012. PubMed DOI

Shor S., Green C., Szantyr B., Phillips S., Liegner K., Burrascano J., Bransfield R., Maloney E.L. Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group. Antibiotics. 2019;8:269. doi: 10.3390/antibiotics8040269. PubMed DOI PMC

Rudenko N., Golovchenko M., Kybicova K., Vancova M. Metamorphoses of Lyme disease spirochetes: Phenomenon of Borrelia persisters. Parasit. Vectors. 2019;12:237. doi: 10.1186/s13071-019-3495-7. PubMed DOI PMC

Sloupenska K., Dolezilkova J., Koubkova B., Hutyrova B., Racansky M., Horak P., Golovchenko M., Raska M., Rudenko N., Krupka M. Seroprevalence of antibodies against tick-borne pathogens in czech patients with suspected post-treatment lyme disease syndrome. Microorganisms. 2021;9:2217. doi: 10.3390/microorganisms9112217. PubMed DOI PMC

McHugh N.J., Tansley S.L. Autoantibodies in myositis. Nat. Rev. Rheumatol. 2018;14:290–302. doi: 10.1038/nrrheum.2018.56. PubMed DOI

Yoo I.S., Kim J. The Role of Autoantibodies in Idiopathic Inflammatory Myopathies. J. Rheum. Dis. 2019;26:165. doi: 10.4078/jrd.2019.26.3.165. DOI

Berthold A., Faucillion M.-L., Nilsson I., Golovchenko M., Lloyd V., Bergström S., Rudenko N. Cultivation Methods of spirochetes from Borrelia burgdorferi sensu lato complex and relapsing fever Borrelia. J. Vis. Exp. 2022;2022:1–20. doi: 10.3791/64431. PubMed DOI

Conrad K., Röber N., Andrade L.E.C., Mahler M. The clinical relevance of anti-DFS70 Autoantibodies. Clin. Rev. Allergy Immunol. 2017;52:202–216. doi: 10.1007/s12016-016-8564-5. PubMed DOI

Maeda M.H., Tsuji S., Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain. 2012;135:1767–1777. doi: 10.1093/brain/aws106. PubMed DOI

Reimers C.D., de Koning J., Neubert U., Preac-Mursic V., Koster J.G., Müller-Felber W., Pongratz D.E., Duray P.H. Borrelia burgdorferi myositis: Report of eight patients. J. Neurol. 1993;240:278–283. doi: 10.1007/BF00838161. PubMed DOI

Nilsson K., Skoog E., Jones V., Labbé Sandelin L., Björling C., Fridenström E., Edvinsson M., Mårtensson A., Olsen B. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure. PLoS ONE. 2021;16:e0247384. doi: 10.1371/journal.pone.0247384. PubMed DOI PMC

Bundell C., Rojana-udomsart A., Mastaglia F., Hollingsworth P., McLean-Tooke A. Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Pathology. 2016;48:363–366. doi: 10.1016/j.pathol.2016.03.012. PubMed DOI

Rönnelid J., Barbasso Helmers S., Storfors H., Grip K., Rönnblom L., Franck-Larsson K., Nordmark G., Lundberg I.E. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun. Rev. 2009;9:58–61. doi: 10.1016/j.autrev.2009.03.005. PubMed DOI

Tokarska-Rodak M., Niedźwiadek J., Fota-Markowska H., Śmiechowicz F., Gajownik B., Modrzewska R., Kozioł-Montewka M. Antinuclear antibodies in patients with Lyme disease. New Med. 2010;4:152–155.

Bolz D.D., Weis J.J. Molecular mimicry to Borrelia burgdorferi: Pathway to autoimmunity? Autoimmunity. 2004;37:387–392. doi: 10.1080/08916930410001713098. PubMed DOI

Chang S.E., Feng A., Meng W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 2021;12:5417. doi: 10.1038/s41467-021-25509-3. PubMed DOI PMC

Antigenicity and immunogenicity of different morphological forms of Borrelia burgdorferi sensu lato spirochetes

Concurrent Infection of the Human Brain with Multiple Borrelia Species